Clinical Trials Logo

Clinical Trial Summary

According to Morgan et. al. (J Neurosurg 101:1026-1029, 2004): bilirubin as a cerebrospinal fluid marker of sentinel subarachnoid hemorrhage: a preliminary report in pigs, we're going to test the hypothesis in the cerebrospinal fluid of spontaneous subarachnoid hemorrhage patients.


Clinical Trial Description

According to Morgan et. al. (J Neurosurg 101:1026-1029, 2004): bilirubin as a cerebrospinal fluid marker of sentinel subarachnoid hemorrhage: a preliminary report in pigs, we're going to test the hypothesis in the cerebrospinal fluid of spontaneous subarachnoid hemorrhage patients. We'll collect the serial cerebrospinal fluid in 15-20 spontaneous subarachnoid hemorrhage patients to see the time sequence of changes in bilirubin levels. ;


Study Design

Observational Model: Case Control, Primary Purpose: Screening, Time Perspective: Longitudinal


Related Conditions & MeSH terms


NCT number NCT00173095
Study type Observational
Source National Taiwan University Hospital
Contact Chang-Mu Chen, MD
Phone 886-2-23123456
Email cmchen10@ms27.hinet.net
Status Recruiting
Phase N/A
Start date January 2005
Completion date January 2008

See also
  Status Clinical Trial Phase
Completed NCT04377347 - Long-term Effects of Time to Treatment in Subarachnoid Haemorrhage
Completed NCT01801306 - A New Minimal-invasive Brain Tissue Probe Applying Near Infrared Spectroscopy N/A
Completed NCT03786068 - Time to Specialized Admission in Case of Severe Brain Haemorrhage.
Not yet recruiting NCT06439615 - Baricitinib for the Lung Injury Following Spontaneous SAH Phase 2